Pharmaceutical
Technology
Health

Repligen

$69.17
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.83 (2.73%) Today
+$0.31 (0.45%) After Hours

Why Robinhood?

You can buy or sell Repligen and other stocks, options, ETFs, and crypto commission-free!

About

Repligen Corp. provides advanced bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. The firm serves through the following product lines: Chromatography; Filtration; and OEM Products (Proteins). Read More The Chromatography product line includes a number of products used in the downstream purification and quality control of biological drugs. The Filtration products offer a number of advantages to manufacturers of biologic drugs at volumes that span from pilot studies to clinical and commercial-scale production. The OEM products are represented by Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification, and cell culture growth factor products. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Employees
548
Headquarters
Waltham, Massachusetts
Founded
1981
Market Cap
3.03B
Price-Earnings Ratio
150.94
Dividend Yield
0.00
Average Volume
391.93K
High Today
$70.41
Low Today
$67.54
Open Price
$67.54
Volume
163.55K
52 Week High
$71.21
52 Week Low
$42.80

Collections

Pharmaceutical
Technology
Health
Biotechnology
Manufacturing
Medical
US
North America

News

Yahoo FinanceMay 10

Edited Transcript of RGEN earnings conference call or presentation 9-May-19 12:30pm GMT

Q1 2019 Repligen Corp Earnings Call WALTHAM May 10, 2019 (Thomson StreetEvents) -- Edited Transcript of Repligen Corp earnings conference call or presentation Thursday, May 9, 2019 at 12:30:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * Anthony J. Hunt Repligen Corporation - CEO, President, Director & Member of Scientific Advis...

24
Yahoo FinanceMay 9

Repligen (RGEN) Q1 Earnings and Revenues Beat Estimates

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks.

32
Yahoo FinanceMay 9

Repligen: 1Q Earnings Snapshot

WALTHAM, Mass. (AP) _ Repligen Corp. (RGEN) on Thursday reported first-quarter profit of $8.1 million. The Waltham, Massachusetts-based company said it had net income of 17 cents per share. Earnings, adjusted for one-time gains and costs, came to 28 cents per share. The drug developer posted revenue of $60.6 million in the period. Repligen expects full-year earnings in the range of 84 cents to 90 cents per share. Repligen shares have risen 28% since the beginning of the year. The stock has climbed 67% i...

19

Earnings

$0.11
$0.17
$0.22
$0.28
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 1, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.